GlassScriptPhysician profile
Camelia L Salanta
NPI 1063675114
$4,570.14
in general payments reported to CMS, 2019-2025
43 companies · $822 in 2025
The $822 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $468 · 2021: $779 · 2022: $670 · 2023: $764 · 2024: $646 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $827.95 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $744.88 | 2019-2025 | |
| Amgen INC. | $366.23 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $353.63 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $302.14 | 2020-2025 | Mounjaro, Trulicity, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $284.34 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $227.18 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $160.81 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Astellas Pharma US INC | $102.86 | 2019-2020 | |
| Exact Sciences Corporation | $94.81 | 2023-2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $94.04 | 2021-2024 | Injectafer |
| Dexcom, INC. | $75.59 | 2022-2023 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $61.38 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $60.34 | 2022 | |
| Amneal Pharmaceuticals LLC | $50.44 | 2023-2024 | Unithroid |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camelia Salanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.